St. Luke's Medical Center
Quezon City, Philippines
Hospital in Quezon City
279 E Rodriguez Sr. Ave, Quezon City, 1112 Metro Manila
650 Beds
About St. Luke's Medical Center
St. Luke's Medical Center – Quezon City is a hospital in Quezon City, Metro Manila, Philippines. Forming as a part of St. Luke's Medical Center group of hospitals, it was founded in 1903 by the American ...
There are 650 beds in St. Luke's Medical Center.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
8
Allergan
7
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
4
Boehringer Ingelheim
3
Hoffmann-La Roche
3
Genentech, Inc.
2
Imunon
2
Takeda
2
Agennix
1
Apellis Pharmaceuticals, Inc.
1
Asan Medical Center
1
Clinical Trials at St. Luke's Medical Center
During the past decade, St. Luke's Medical Center conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 29 clinical trials were completed, i.e. on
average, 111.5% percent of trials that started reached the finish line to date. In the past 5 years, 10 clinical trials started and 15 clinical trials were completed. i.e. 150%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study Comparing Bevacizumab Therapy With or Without Erlotinib for First-Line Treatment of Non-Small Cell Lung Cancer (ATLAS)
2006-01-01
2014-11-01
Completed
1,145
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
2006-10-04
2016-04-12
Completed
24,081
A Phase 3 Study of Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC)
2006-07-01
2012-09-01
Completed
208
A Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE)
2007-05-01
2010-03-01
Completed
865
Efficacy and Safety Study of 3 Thalidomide Doses for the Treatment of Relapsed Refractory Multiple Myeloma
2006-02-01
2009-01-01
Completed
499
A Study of Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell Lymphoma
2007-07-26
2011-11-30
Terminated
787
A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast Cancer
2008-02-12
2018-11-23
Completed
808
Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC)
2008-05-01
2016-08-01
Completed
701
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "St. Luke's Medical Center" #1 sponsor was "Pfizer" with 8 trials, followed by "Allergan" with 7 trials
sponsored, "Pfizer's Upjohn has merged with Mylan to form Viatris Inc." with 4 trials sponsored, "Boehringer Ingelheim" with 3 trials sponsored and "Hoffmann-La Roche"
with 3 trials sponsored. Other sponsors include 32 different institutions and
companies that sponsored additional 39 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "St. Luke's Medical Center"
#1 collaborator was "Allergan" with 1 trials as a collaborator, "Baguio General Hospital and Medical Center, Philippines" with 1 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator, "Chong Hua Hospital, Philippines" with 1 trials as a collaborator and "Chugai Pharmaceutical" with 1 trials as a collaborator. Other collaborators include 28 different institutions and companies that were
collaborators in the rest 38 trials.
Clinical Trials Conditions at St. Luke's Medical Center
According to Clinical.Site data, the most researched conditions in "St. Luke's Medical Center" are
"Gastroparesis" (4 trials), "Diabetes Mellitus" (3 trials), "Hepatocellular Carcinoma" (3 trials), "Rheumatoid Arthritis" (3 trials) and "Systemic Lupus Erythematosus" (3 trials). Many other conditions were trialed in "St. Luke's Medical Center" in a lesser frequency.
Clinical Trials Intervention Types at St. Luke's Medical Center
Most popular intervention types in "St. Luke's Medical Center" are "Drug" (50 trials), "Biological" (9 trials), "Device" (3 trials), "Other" (3 trials) and "Combination Product" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (14 trials), "Carboplatin" (3 trials), "Paclitaxel" (3 trials), "Relamorelin" (3 trials) and "ATM-AVI" (2 trials). Other intervention names were less common.
Clinical Trials Genders at St. Luke's Medical Center
The vast majority of trials in "St. Luke's Medical Center" are
60 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at St. Luke's Medical Center
Currently, there are NaN active trials in "St. Luke's Medical Center".
undefined are not yet recruiting,
7 are recruiting,
4 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 41 completed trials in St. Luke's Medical Center,
undefined suspended trials,
and 8 terminated clinical trials to date.
Out of the total trials that were conducted in St. Luke's Medical Center, 2 "Phase 1"
clinical trials were conducted, 9 "Phase 2" clinical
trials and 43 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 5 trials, and there were
also 1 trials that are defined as “Not Applicable".
Departments of St. Luke's Medical Center
St. Luke's Medical Center has several departments that took part in Clinical trials: "St. Luke's Medical Center, Human Cancer Biobank Research Center" - 2 trials
Departments List
Name
City
Trials